Physician profile
Warren Swee
NPI 1639387624
$244,714.49
in general payments reported to CMS, 2019-2025
32 companies · $50K in 2025
The $50K reported for 2025 was more than what 97% of Vascular & Interventional Radiology providers received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,784 · 2020: $8,663 · 2021: $24K · 2022: $50K · 2023: $57K · 2024: $46K · 2025: $50K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $135K · Consulting Fee: $11K · Food and Beverage: $5,255 · Travel and Lodging: $2,760.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $135,000.00 |
| Consulting Fee | $10,500.00 |
| Food and Beverage | $5,255.25 |
| Travel and Lodging | $2,760.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $225,808.39 | 2019-2025 | Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac, Angiovac |
| Cardiovascular Systems INC. | $14,092.73 | 2019-2022 | |
| Nevro Corp. | $670.74 | 2024 | Senza |
| Philips North America LLC | $596.76 | 2019-2023 | |
| Abbott Laboratories | $596.43 | 2019-2025 | Diamondback Peripheral, Supera |
| Janssen Pharmaceuticals, INC | $557.47 | 2019-2022 | |
| Boston Scientific Corporation | $465.10 | 2019-2025 | Varithena Administration Pack, General - Vascular Intervention, General - Angioplasty |
| Cms Imaging, INC. | $393.51 | 2023-2024 | |
| Sirtex Medical INC | $235.83 | 2019-2020 | |
| Vasorum USA INC. | $164.28 | 2022 | |
| Acera Surgical, INC. | $129.00 | 2022 | |
| Medtronic Vascular, INC. | $120.53 | 2019 | |
| Janssen Scientific Affairs, LLC | $112.40 | 2021 | |
| Amgen INC. | $104.37 | 2019 | |
| Veryan Medical Incorporated | $101.15 | 2021-2023 | Biomimics 3d Vascular Stent System |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $69.00 | 2019 | |
| Asahi Intecc USA, INC. | $68.57 | 2020-2024 | Peripheral Vascular |
| Bard Peripheral Vascular, INC. | $62.40 | 2022-2023 | Fluency Endovascular Stent Graft |
| Siemens Medical Solutions USA, INC. | $54.61 | 2019 | |
| Avanos Medical | $44.95 | 2025 | Genvisc 850 Sodium Hyaluronate |
| Medtronic, INC. | $36.38 | 2021-2023 | Venaseal |
| Shockwave Medical, INC | $26.84 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Becton, Dickinson and Company | $25.35 | 2024 | Venclose Maven Catheter |
| Biocompatibles, INC. | $23.63 | 2019 | |
| Cook Medical LLC | $22.98 | 2023 | Zilver Ptx |
| Bsn Medical INC | $21.43 | 2020 | |
| Globus Medical, INC. | $20.59 | 2025 | Senza |
| Tactile Systems Technology INC | $20.34 | 2024 | Flexitouch Plus, Entre Plus |
| Surmodics, INC. | $19.88 | 2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy |
| Terumo Medical Corporation | $18.58 | 2021 | |
| Cashflow Solutions, LLC | $16.67 | 2024 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
| Therapeuticsmd, INC. | $13.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Warren Swee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.